MCUJF — MEDICURE INC
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1133519 ·
Manitoba, Canada
Last close
$1.90
Market Cap
$19.83M
52W High
$1.93
52W Low
$0.67
ADV30
12,283
Next earnings
2026-11-19
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,427,000 | 3,198,000 | -1,353,000 | -1,428,000 | 22,594,000 | 1,832,000 | 11,023,000 |
| Mar 2026 | 7,947,000 | 3,521,000 | -367,000 | -406,000 | 23,378,000 | 1,542,000 | 10,731,000 |
| Dec 2025 | 8,543,000 | 2,697,000 | -4,224,000 | -4,221,000 | 24,949,000 | 3,835,000 | 12,040,000 |
| Sep 2025 | 8,159,000 | 2,773,000 | -1,310,000 | -1,396,000 | 26,723,000 | 4,118,000 | 9,415,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,041,000
Investing CF
$-1,882,000
Financing CF
$-438,000
CapEx
$-448,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.32
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-74,394,000
Inventory
$3,188,000
Receivables
$5,687,000
ST Investments
—
EBIT TTM
$-6,571,000
Pretax Income TTM
$-6,630,000
Interest Exp TTM
$2,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$32,076,000
EBITDA
$-5,617,000
Free Cash Flow
$204,375
Enterprise Value
$18,275,542
Total Cash
$1,832,000
Total Debt
$696,000
Shares Out
10,436,313
Trailing EPS
$-0.52
Book Value
$0.80
ROE
-49.9%
ROA
-17.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,855,000 | -6,888,000 | -7,097,000 | 24,949,000 | 12,040,000 | 12,909,000 | -560,000 |
| Dec 2024 | 21,907,000 | -2,737,000 | -1,039,000 | 29,679,000 | 8,901,000 | 20,778,000 | 1,377,000 |
| Dec 2023 | 21,694,000 | -854,000 | -922,000 | 28,059,000 | 8,163,000 | 19,896,000 | 2,079,000 |
| Dec 2022 | 23,065,000 | 1,193,000 | 1,365,000 | 29,898,000 | 8,893,000 | 21,005,000 | 1,828,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.65
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NEUP | Neuphoria Therapeutics Inc. | $19.73M | $3.65 | — |
| MRKR | Marker Therapeutics, Inc. | $19.17M | $1.15 | — |
| AKTX | Akari Therapeutics Plc | $18.99M | $9.76 | — |
| ATOS | ATOSSA THERAPEUTICS, INC. | $18.96M | $1.90 | — |
| PBM | PSYENCE BIOMEDICAL LTD. | $21.21M | $5.56 | — |
News headlines (Yahoo Finance, 1h cache)
Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
2026-09-08 22:25 · Yahoo
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
2026-08-14 21:00 · Yahoo
Medicure Announces CFO Change
2026-07-03 21:00 · Yahoo
Medicure Inc (MCUJF) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions ...
2026-05-25 21:00 · Yahoo
Medicure Announces AGM Results and Appointment of New Director
2026-05-21 21:00 · Yahoo
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
2026-05-21 21:00 · Yahoo
Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
2026-04-23 22:15 · Yahoo
Medicure Announces Resignation of President and Chief Operating Officer
2026-04-17 23:35 · Yahoo
Medicure Inc (MCUJF) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic Expansion ...
2026-08-17 20:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.